J.P. Morgan Securities: Rezolute (RZLT.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $7.00.
Zhitong FinanceApr 20 00:30
Rezolute Analyst Ratings
BenzingaApr 20 00:25
JMP Securities Reiterates Market Outperform on Rezolute, Maintains $7 Price Target
BenzingaApr 20 00:28
JMP Securities Reiterates Market Outperform on Rezolute, Maintains $7 Price Target
BenzingaApr 19 01:34
Rezolute Analyst Ratings
BenzingaApr 18 19:59
Optimistic Buy Rating for Rezolute's RZ402 Drug Candidate Amid Promising DME Treatment Prospects
TipRanksApr 18 12:35
Rezolute (RZLT.US) was first covered by Maxim Group and given a buy rating, with a target price of $8.00.
Zhitong FinanceApr 9 23:40
Rezolute Analyst Ratings
BenzingaApr 9 23:34
Rezolute Analyst Ratings
BenzingaMar 7 20:29
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG), ITeos Therapeutics (ITOS) and Rezolute (RZLT)
TipRanksMar 7 19:30
Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and KalVista Pharmaceuticals (KALV)
TipRanksFeb 14 19:20
Rezolute Analyst Ratings
BenzingaFeb 14 19:19
Buy Rating Affirmed for Rezolute Amidst Promising Clinical Developments and Stable Financials
TipRanksFeb 14 13:15
Buy Rating Affirmed for Rezolute's RZ358 Based on Untapped Market Potential and Therapeutic Efficacy
TipRanksFeb 8 19:19
Rezolute's Promising Drug Pipeline and Market Position Validate Buy Rating: An Analysis of RZ358 and RZ402 Potential
TipRanksNov 17, 2023 19:22
JMP Securities Maintains Market Outperform on Rezolute, Lowers Price Target to $7
BenzingaNov 15, 2023 00:31
Rezolute Analyst Ratings
BenzingaNov 15, 2023 00:30
Analysts Are Bullish on Top Healthcare Stocks: Benitec Biopharma (BNTC), Rezolute (RZLT)
TipRanksNov 14, 2023 13:30
Cantor Fitzgerald Reiterates Overweight on Rezolute, Maintains $5 Price Target
BenzingaSep 19, 2023 21:11
Rezolute Analyst Ratings
BenzingaSep 19, 2023 21:10
No Data
No Data